Agnesian Healthcare Center is categorized under Sports Medicines in Fond Du Lac, WI .
Agnesian Healthcare Center was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Nicole Auxier, Office Manager at the company’s single location by writing to 421 Camelot Drive, Fond Du Lac, Wisconsin WI 54935 or by phoning (920) 923-7940. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Agnesian Healthcare Center |
| Contact Person: | Nicole Auxier, Office Manager |
| Address: | 421 Camelot Drive, Fond Du Lac, Wisconsin 54935 |
| Phone Number: | (920) 923-7940 |
| Website Address: | agnesian.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Sports Medicines |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Agnesian Healthcare Center was started in 0 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Nicole Auxier, Office Manager for inquiries that concern Agnesian Healthcare Center by calling the company number (920) 923-7940, as your correspondence is most welcome. Additionally, the physical location of the single location of Agnesian Healthcare Center can be found at the coordinates 43.75959,-88.40684 as well as the street address 421 Camelot Drive in Fond Du Lac, Wisconsin 54935.
For its online presence, you may visit Agnesian Healthcare Center’s website at agnesian.com and engage with its social media outlets through on Twitter and on Facebook.